World Health Organization, Suva, Fiji.
World Health Organization, Apia, Western Samoa.
Am J Trop Med Hyg. 2022 Mar 15;106(5_Suppl):39-47. doi: 10.4269/ajtmh.21-1085. Print 2022 May 11.
We discuss the experience of some Pacific island countries in introducing the new WHO-recommended treatment protocol for lymphatic filariasis-a triple-drug therapy composed of ivermectin, diethylcarbamazine, and albendazole. The successful rollout of the new treatment protocol was dependent on strong partnerships among these countries' ministries of health, WHO, and other stakeholders. Effective communication among these partners allowed for lessons learned to cross borders and have a positive impact on the experiences of other countries. We also describe various challenges confronted during this process and the ways these countries overcame them.
我们讨论了一些太平洋岛国在引入世界卫生组织（WHO）新推荐的淋巴丝虫病治疗方案方面的经验，该方案是由伊维菌素、乙胺嗪和阿苯达唑组成的三药疗法。新治疗方案的成功推出依赖于这些国家的卫生部、世界卫生组织（WHO）和其他利益攸关方之间的强有力伙伴关系。这些合作伙伴之间的有效沟通使经验教训得以跨越国界，并对其他国家的经验产生积极影响。我们还描述了在这一过程中遇到的各种挑战以及这些国家克服这些挑战的方式。
